Loading resource…

American College of Cardiology Foundation
Heart failure with improved ejection fraction (HFimpEF) is increasingly recognized as a distinct phenotype characterized by previously reduced left ventricular ejection fraction that improves to above 40%. Despite recovery, patients with HFimpEF remain at risk for adverse outcomes, and their management is an area of active investigation. This review highlights existing clinical gaps and proposes future research directions to refine risk stratification and therapeutic approaches for this evolving population.
No account needed